Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsuda, Y.
Right arrow Articles by Yabuuchi, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsuda, Y.
Right arrow Articles by Yabuuchi, I.

Radiology, Vol 161, 701-705, Copyright © 1986 by Radiological Society of North America

ARTICLES

Hepatic tumors: US contrast enhancement with CO2 microbubbles

Y Matsuda and I Yabuuchi

Enhancement of hepatic tumors on sonograms by injection of carbon dioxide microbubbles into the hepatic artery as a contrast material (enhanced ultrasonography) was performed in 43 patients with various histologically confirmed hepatic tumors. Enhanced sonograms were classified into five patterns according to the relative changes of the echo levels between the tumor and the nontumorous parenchyma of the liver as a result of enhancement: hyperechoic change, isoechoic change, hypoechoic change with hyperechoic rim (rim sign), marginal spotty hyperechoic change, and internal spotty hyperechoic change. Eighty- eight percent of hepatocellular carcinomas showed hyperechoic change, 70% of metastatic tumors exhibited hypoechoic change with the rim sign. The marginal spotty hyperechoic change and the internal spotty hyperechoic change were specific for cavernous hemangioma and fibrous granuloma, respectively. This method of enhancement is useful in assessing the nature of liver tumors and in the detection of small nodules in the liver.


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
K. Takeshima, T. Kumada, H. Toyoda, S. Kiriyama, M. Tanikawa, H. Ichikawa, T. Kawachi, and S. Ogawa
Comparison of IV Contrast-Enhanced Sonography and Histopathology of Pancreatic Cancer
Am. J. Roentgenol., November 1, 2005; 185(5): 1193 - 1200.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
M. Gotoh, T. Nakatani, T. Masuda, Y. Mizuguchi, M. Sakamoto, R. Tsuchiya, H. Kato, and K. Furuta
Prediction of Invasive Activities in Hepatocellular Carcinomas with Special Reference to {alpha}-Fetoprotein and Des-{gamma}-carboxyprothrombin
Jpn. J. Clin. Oncol., October 1, 2003; 33(10): 522 - 526.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
R.-C. Chen, W.-T. Chen, H.-Y. Tu, N.-Y. Cheng, C.-K. Wang, L.-Y. Liao, C.-S. Wang, and P.-H. Chen
Assessment of Vascularity in Hepatic Tumors: Comparison of Power Doppler Sonography and Intraarterial CO2-Enhanced Sonography
Am. J. Roentgenol., January 1, 2002; 178(1): 67 - 73.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
K. Numata, K. Tanaka, T. Kiba, S. Matsumoto, S. Iwase, K. Hara, H. Kirikoshi, K. Morita, S. Saito, and H. Sekihara
Nonresectable Hepatocellular Carcinoma: Improved Percutaneous Ethanol Injection Therapy Guided by CO2-Enhanced Sonography
Am. J. Roentgenol., October 1, 2001; 177(4): 789 - 798.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1986 by the Radiological Society of North America.